These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12656750)

  • 1. Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome.
    Go RS; Johnston KL
    Eur J Haematol; 2003 Apr; 70(4):246-8. PubMed ID: 12656750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
    Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms.
    Ye XN; Zhou XP; Wei JY; Xu GX; Li Y; Mao LP; Huang J; Ren YL; Mei C; Wang JH; Lou YJ; Ma LY; Yu WJ; Ye L; Xie LL; Luo YW; Hu C; Niu LM; Dou MH; Jin J; Tong HY
    Leuk Lymphoma; 2016; 57(6):1311-8. PubMed ID: 26372888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)].
    Kumagawa M; Suzuki K; Nagano M; Takamatsu Y; Suzumiya J; Tamura K
    Rinsho Ketsueki; 2003 Jun; 44(6):404-6. PubMed ID: 12884821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome.
    Estey EH; Kantarjian H; Keating M
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):1-5. PubMed ID: 8290966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii (TAR).
    Strippoli P; Savoia A; Iolascon A; Tonelli R; Savino M; Giordano P; D'Avanzo M; Massolo F; Locatelli F; Borgna C; De Mattia D; Zelante L; Paolucci G; Bagnara GP
    Br J Haematol; 1998 Nov; 103(2):311-4. PubMed ID: 9827898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebound thrombocytosis is associated with response in AML patients treated with venetoclax and hypomethylating agents.
    Othman TA; Mei M; Zhang J; Aldoss I; Stein A; Forman SJ; Marcucci G; Pullarkat V
    Am J Hematol; 2021 May; 96(5):E140-E143. PubMed ID: 33524204
    [No Abstract]   [Full Text] [Related]  

  • 8. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
    Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
    [No Abstract]   [Full Text] [Related]  

  • 9. Defective c-Mpl signaling in the syndrome of thrombocytopenia with absent radii.
    Ballmaier M; Schulze H; Cremer M; Folman CC; Strauss G; Welte K
    Stem Cells; 1998; 16 Suppl 2():177-84. PubMed ID: 11012189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome.
    Lee ST; Jang JH; Suh HC; Hahn JS; Ko YW; Min YH
    Am J Hematol; 2001 Dec; 68(4):237-45. PubMed ID: 11754412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
    Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
    Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML).
    Advani AS; Li H; Michaelis LC; Medeiros BC; Liedtke M; List AF; O'Dwyer K; Othus M; Erba HP; Appelbaum FR
    Leuk Res; 2018 Apr; 67():17-20. PubMed ID: 29407182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Giant platelet-like cell fragments produced from abnormal promyelocytes in acute myelogenous leukemia].
    Sugimoto T; Saigo K; Ryo R; Yamaguchi N
    Rinsho Byori; 1998 Feb; 46(2):182-5. PubMed ID: 9528344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial).
    Willemze R; Suciu S; Muus P; Halkes CJ; Meloni G; Meert L; Karrasch M; Rapion J; Vignetti M; Amadori S; de Witte T; Marie JP
    Ann Hematol; 2014 Jun; 93(6):965-75. PubMed ID: 24682421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetraphocomelia in the syndrome of thrombocytopenia with absent radii (TAR syndrome).
    Anyane-Yeboa K; Jaramillo S; Nagel C; Grebin B
    Am J Med Genet; 1985 Apr; 20(4):571-6. PubMed ID: 3993682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia.
    Huang J; Zhao H; Hong M; Zhu H; Zhu Y; Lian Y; Li S; Li J; Qian S
    BMC Cancer; 2018 Dec; 18(1):1269. PubMed ID: 30567513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy].
    Yata K; Yamada O; Iwato K; Kyo T; Otsuki T; Nakanishi H; Suetsugu Y; Mikami M; Wada H; Yawata Y; Sugihara T
    Rinsho Ketsueki; 2002 Jan; 43(1):41-3. PubMed ID: 11868364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute myelogenous leukemia developed at the 26th week of gestation].
    Tashiro H; Umezawa K; Shirota M; Oka Y; Shirasaki R; Nishi R; Taguchi A; Akiyama N; Kawasugi K; Ayabe T; Shirafuji N
    Rinsho Ketsueki; 2011 Jan; 52(1):18-22. PubMed ID: 21378477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
    Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
    Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
    [No Abstract]   [Full Text] [Related]  

  • 20. Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.
    Lambertenghi-Deliliers G; Annaloro C; Cortelezzi A; Cortellaro M; Della Volpe A; Maiolo AT; Mozzana R; Pogliani E; Pozzoli E; Polli EE
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):16-20. PubMed ID: 2928806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.